Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
In the latest session, Bristol-Myers Squibb Co (NYSE: BMY) closed at $47.62 up 0.11% from its previous closing price of $47.57. In other words, the price has increased by $0.11 from its previous closing price. On the day, 15.79 million shares were traded.
Ratios:
For a deeper understanding of Bristol-Myers Squibb Co’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.41. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.28. In the meantime, Its Debt-to-Equity ratio is 2.95 whereas as Long-Term Debt/Eq ratio is at 2.73.
On April 22, 2025, Cantor Fitzgerald started tracking the stock assigning a Neutral rating and target price of $55.
Jefferies Upgraded its Hold to Buy on December 16, 2024, while the target price for the stock was maintained at $70.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Apr 25 ’25 when Hirawat Samit bought 4,250 shares for $47.58 per share. The transaction valued at 202,215 led to the insider holds 83,513 shares of the business.
BOERNER CHRISTOPHER S. bought 2,000 shares of BMY for $110,096 on Feb 20 ’25. The Chief Executive Officer now owns 104,626 shares after completing the transaction at $55.05 per share. On Feb 14 ’25, another insider, Hirawat Samit, who serves as the EVP,Chief Med.Offr.,Drug Dev. of the company, bought 1,823 shares for $54.84 each. As a result, the insider paid 100,000 and bolstered with 63,932 shares of the company.
Valuation Measures:
As of this moment, Bristol-Myers’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.88, and their Forward P/E ratio for the next fiscal year is 7.84. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.25. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.03 while its Price-to-Book (P/B) ratio in mrq is 5.57.
Stock Price History:
Over the past 52 weeks, BMY has reached a high of $63.33, while it has fallen to a 52-week low of $39.35. The 50-Day Moving Average of the stock is -14.15%, while the 200-Day Moving Average is calculated to be -12.09%.
Shares Statistics:
A total of 2.04B shares are outstanding, with a floating share count of 2.03B. Insiders hold about 0.08% of the company’s shares, while institutions hold 82.36% stake in the company.
